Abstract:Objective: To determine the environmental contamination degree of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in corona virus disease 2019 (COVID-19) wards, to offer gui-dance for the infection control and to improve safety practices for medical staff, by sampling and detecting SARS-CoV-2 nucleic acid from the air of hospital wards, the high-frequency contact surfaces in the contaminated area and the surfaces of medical staff's protective equipment in a COVID-19 designated hospital in Wuhan, China. Methods: From March 11 to March 19, 2020, we collected air samples from the clean area, the buffer room and the contaminated area respectively in the COVID-19 wards using a portable bioaerosol concentrator WA-15. And sterile premoistened swabs were used to sample the high-frequency contacted surfaces in the contaminated area and the surfaces of medical staff's protective equipment including outermost gloves, tracheotomy operator's positive pressure respiratory protective hood and isolation clothing. The SARS-CoV-2 nucleic acid of the samples were detected by real-time fluorescence quantitative PCR. During the isolation medical observation period, those medical staff who worked in the COVID-19 wards were detected for SARS-CoV-2 nucleic acid with oropharyngeal swabs, IgM and IgG antibody in the sera, and chest CT scans to confirm the infection status of COVID-19. Results: No SARS-CoV-2 nucleic acid was detected in the tested samples, including the 90 air samples from the COVID-19 wards including clean area, buffer room and contaminated area, the 38 high-frequency contact surfaces samples of the contaminated area and 16 surface samples of medical staff's protective equipment including outermost gloves and isolation clothing. Moreover, detection of SARS-CoV-2 nucleic acid by oropharyngeal swabs and IgM, IgG antibodies in the sera of all the health-care workers who participated in the treatment for COVID-19 were all negative. Besides, no chest CT scan images of medical staff exhibited COVID-19 lung presentations. Conclusion: Good ventilation conditions, strict disinfection of environmental facilities in hospital wards, guidance for correct habits in patients, and strict hand hygiene during medical staff are important to reduce the formation of viral aerosols, cut down the aerosol load, and avoid cross-infection in isolation wards. In the face of infectious diseases that were not fully mastered but ma-naged as class A, it is safe for medical personnel to be equipped at a high level.

[Principles and Suggestions on Biosafety Protection of Biological Specimen Preservation During Prevalence of COVID-19].

Prevention and Consideration for the Biosafety of Laboratory Testing under Epidemic Condition

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

Detection, Prevention and Treatment of COVID-19 and Opportunities for Nanobiotechnology.

Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China

Current epidemiological and clinical features of COVID-19; a global perspective from China.

Biosafety considerations for laboratory work with SARS-CoV-2

Advices on the Prevention and Control of Nosocomial Infection of Novel Coronavirus Within Children’s Hospitals

[Safety Surveillance and Management of Specimen Associated with SARS in Clinical Laboratory].

Biosafety and Immunology: an Interdisciplinary Field for Health Priority

Protecting Healthcare Personnel from 2019-Ncov Infection Risks: Lessons and Suggestions

Prevention and control of coronavirus disease 2019 (COVID-19) in public places

Interim Proposal for Collecting and Handling of Microbiology Specimens from Patients with COVID‐19 in General Hospitals

Predictive Analysis and Countermeasures in Response to COVID-19 Epidemic in 2020-2021

Biosafety materials: an emerging new research direction of materials science from the COVID-19 outbreak

Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis

The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023)

Epidemiological analysis of COVID‐19 and practical experience from China

[Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment]

An Interim Review of Lessons from the Novel Coronavirus (Sars-Cov-2) Outbreak in China

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence